Clinical Trial Update: Gala Early Feasibility Study of RheOx [NA]

View source ↗

Summary

An early feasibility study update for RheOx by Gala Therapeutics; current status and results posted in 2022 with indications including chronic bronchitis and CO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease Bronchitis

Drugs mentioned

• RheOx

Snippet

Sponsor: Gala Therapeutics, Inc. | Conditions: Chronic Bronchitis, Copd Bronchitis | NA | Status: UNKNOWN | Results posted: 2022-05-09